Trial Outcomes & Findings for Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms (NCT NCT02919267)
NCT ID: NCT02919267
Last Updated: 2020-05-26
Results Overview
COMPLETED
NA
40 participants
From the beginning of OLV until 60 minutes
2020-05-26
Participant Flow
As mentioned into the Methods section of the protocol, each patients that were excluded after randomization were replaced by a new randomized patient. We had to randomized 49 patients in order to analyze a total of 39 patients.
One patient was excluded after the study was completed because when we started the analysis of the results, we realized that one of the patient had an air leak during the study period that was not recognized by the investigator. Since the study was completed, we could not randomized a new patient.
Participant milestones
| Measure |
Intra-pulmonary Pressure Measurements With Double-lumen Tube
For patients randomized to the intra-pulmonary pressure measurements, a pressure-tubing catheter was connected to the luerlock adaptor of the BB or to the adaptor located on the side of the occluding system mounted at the extremity of the DLT. The catheter was connected to a differential pressure transducer. Signals were amplified with a CD15 Carrier Demodulator then digitized at 5 Hz and sampled using an MP100 analogic/numeric system. Continuous pressure measurements were recorded before and after pleural opening by the surgeon. Tracings were recorded and subsequent off-line analyses were accomplished using ACQKnowledge and pressures were averaged every 30 seconds, excluding aberrant measures (above and below 2 SD of the mean).
|
Intra-pulmonary Pressure Determination With Bronchial Blocker
For patients randomized to the intra-pulmonary pressure measurements, a pressure-tubing catheter was connected to the luerlock adaptor of the BB or to the adaptor located on the side of the occluding system mounted at the extremity of the DLT. The catheter was connected to a differential pressure transducer. Signals were amplified with a CD15 Carrier Demodulator then digitized at 5 Hz and sampled using an MP100 analogic/numeric system. Continuous pressure measurements were recorded before and after pleural opening by the surgeon. Tracings were recorded and subsequent off-line analyses were accomplished using ACQKnowledge and pressures were averaged every 30 seconds, excluding aberrant measures (above and below 2 SD of the mean).
|
Gas Movement Quantification With Double-lumen Tube
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
Gas Movement Quantification With Bronchial Blocker
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
|---|---|---|---|---|
|
Overall Study
STARTED
|
10
|
12
|
13
|
14
|
|
Overall Study
COMPLETED
|
10
|
9
|
10
|
10
|
|
Overall Study
NOT COMPLETED
|
0
|
3
|
3
|
4
|
Reasons for withdrawal
| Measure |
Intra-pulmonary Pressure Measurements With Double-lumen Tube
For patients randomized to the intra-pulmonary pressure measurements, a pressure-tubing catheter was connected to the luerlock adaptor of the BB or to the adaptor located on the side of the occluding system mounted at the extremity of the DLT. The catheter was connected to a differential pressure transducer. Signals were amplified with a CD15 Carrier Demodulator then digitized at 5 Hz and sampled using an MP100 analogic/numeric system. Continuous pressure measurements were recorded before and after pleural opening by the surgeon. Tracings were recorded and subsequent off-line analyses were accomplished using ACQKnowledge and pressures were averaged every 30 seconds, excluding aberrant measures (above and below 2 SD of the mean).
|
Intra-pulmonary Pressure Determination With Bronchial Blocker
For patients randomized to the intra-pulmonary pressure measurements, a pressure-tubing catheter was connected to the luerlock adaptor of the BB or to the adaptor located on the side of the occluding system mounted at the extremity of the DLT. The catheter was connected to a differential pressure transducer. Signals were amplified with a CD15 Carrier Demodulator then digitized at 5 Hz and sampled using an MP100 analogic/numeric system. Continuous pressure measurements were recorded before and after pleural opening by the surgeon. Tracings were recorded and subsequent off-line analyses were accomplished using ACQKnowledge and pressures were averaged every 30 seconds, excluding aberrant measures (above and below 2 SD of the mean).
|
Gas Movement Quantification With Double-lumen Tube
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
Gas Movement Quantification With Bronchial Blocker
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
|---|---|---|---|---|
|
Overall Study
Protocol Violation
|
0
|
3
|
3
|
4
|
Baseline Characteristics
Physiology of Lung Collapse Under One-Lung Ventilation: Underlying Mechanisms
Baseline characteristics by cohort
| Measure |
Intra-pulmonary Pressure Measurements With Double-lumen Tube
n=10 Participants
For patients randomized to the intra-pulmonary pressure measurements, a pressure-tubing catheter was connected to the luerlock adaptor of the BB or to the adaptor located on the side of the occluding system mounted at the extremity of the DLT. The catheter was connected to a differential pressure transducer. Signals were amplified with a CD15 Carrier Demodulator then digitized at 5 Hz and sampled using an MP100 analogic/numeric system. Continuous pressure measurements were recorded before and after pleural opening by the surgeon. Tracings were recorded and subsequent off-line analyses were accomplished using ACQKnowledge and pressures were averaged every 30 seconds, excluding aberrant measures (above and below 2 SD of the mean).
|
Intra-pulmonary Pressure Determination With Bronchial Blocker
n=9 Participants
For patients randomized to the intra-pulmonary pressure measurements, a pressure-tubing catheter was connected to the luerlock adaptor of the BB or to the adaptor located on the side of the occluding system mounted at the extremity of the DLT. The catheter was connected to a differential pressure transducer. Signals were amplified with a CD15 Carrier Demodulator then digitized at 5 Hz and sampled using an MP100 analogic/numeric system. Continuous pressure measurements were recorded before and after pleural opening by the surgeon. Tracings were recorded and subsequent off-line analyses were accomplished using ACQKnowledge and pressures were averaged every 30 seconds, excluding aberrant measures (above and below 2 SD of the mean).
|
Gas Movement Quantification With Double-lumen Tube
n=10 Participants
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
Gas Movement Quantification With Bronchial Blocker
n=10 Participants
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
Total
n=39 Participants
Total of all reporting groups
|
|---|---|---|---|---|---|
|
Age, Continuous
|
58 years
STANDARD_DEVIATION 10 • n=5 Participants
|
67 years
STANDARD_DEVIATION 7 • n=7 Participants
|
64 years
STANDARD_DEVIATION 13 • n=5 Participants
|
64 years
STANDARD_DEVIATION 13 • n=4 Participants
|
63 years
STANDARD_DEVIATION 11 • n=21 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
8 Participants
n=5 Participants
|
7 Participants
n=4 Participants
|
28 Participants
n=21 Participants
|
|
Sex: Female, Male
Male
|
3 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
3 Participants
n=4 Participants
|
11 Participants
n=21 Participants
|
|
Weight (kg)
|
73 kilograms
STANDARD_DEVIATION 21 • n=5 Participants
|
76 kilograms
STANDARD_DEVIATION 26 • n=7 Participants
|
66 kilograms
STANDARD_DEVIATION 12 • n=5 Participants
|
65 kilograms
STANDARD_DEVIATION 10 • n=4 Participants
|
70 kilograms
STANDARD_DEVIATION 18 • n=21 Participants
|
|
Height (cm)
|
163 centimeters
STANDARD_DEVIATION 7 • n=5 Participants
|
163 centimeters
STANDARD_DEVIATION 10 • n=7 Participants
|
160 centimeters
STANDARD_DEVIATION 10 • n=5 Participants
|
162 centimeters
STANDARD_DEVIATION 12 • n=4 Participants
|
162 centimeters
STANDARD_DEVIATION 10 • n=21 Participants
|
|
BMI (kg/m2)
|
28 kilograms/m^2
STANDARD_DEVIATION 8 • n=5 Participants
|
28 kilograms/m^2
STANDARD_DEVIATION 7 • n=7 Participants
|
26 kilograms/m^2
STANDARD_DEVIATION 5 • n=5 Participants
|
25 kilograms/m^2
STANDARD_DEVIATION 4 • n=4 Participants
|
27 kilograms/m^2
STANDARD_DEVIATION 6 • n=21 Participants
|
|
Forced expiratory volume in one second (FEV1) (% of predicted)
|
86 % of predicted value
STANDARD_DEVIATION 21 • n=5 Participants
|
90 % of predicted value
STANDARD_DEVIATION 14 • n=7 Participants
|
92 % of predicted value
STANDARD_DEVIATION 20 • n=5 Participants
|
93 % of predicted value
STANDARD_DEVIATION 20 • n=4 Participants
|
90 % of predicted value
STANDARD_DEVIATION 18 • n=21 Participants
|
|
Time tu pleural opening (min)
|
14 minutes
STANDARD_DEVIATION 6 • n=5 Participants
|
12 minutes
STANDARD_DEVIATION 6 • n=7 Participants
|
12 minutes
STANDARD_DEVIATION 4 • n=5 Participants
|
14 minutes
STANDARD_DEVIATION 4 • n=4 Participants
|
13 minutes
STANDARD_DEVIATION 5 • n=21 Participants
|
|
Side of surgery (R/L)
Right-sided surgery
|
7 Participants
n=5 Participants
|
6 Participants
n=7 Participants
|
6 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
24 Participants
n=21 Participants
|
|
Side of surgery (R/L)
Left-sided surgery
|
3 Participants
n=5 Participants
|
3 Participants
n=7 Participants
|
4 Participants
n=5 Participants
|
5 Participants
n=4 Participants
|
15 Participants
n=21 Participants
|
PRIMARY outcome
Timeframe: From the beginning of OLV until 60 minutesOutcome measures
| Measure |
Gas Movement Quantification With Double-lumen Tube
n=10 Participants
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
Gas Movement Quantification With Bronchial Blocker
n=10 Participants
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
|---|---|---|
|
Quantification of Gas Volume Coming From Ambient Air Towards the Alveoli Space of the Non-ventilated Lung During OLV With the Use of DLT and BB.
|
504 milliliters (mL)
Standard Error 85
|
630 milliliters (mL)
Standard Error 86
|
SECONDARY outcome
Timeframe: From the beginning until 10 minutes of OLVIntra-pulmonary pressure measured from initiation of OLV to pleural opening were similarly analyzed using a two-way ANOVA. Two experimental factors, one associated to the comparison between two groups (DLT versus BB), factor fixed and one associated to the comparison among results from the time periods (0 to 10 minutes), factor fixed with interaction terms between the fixed factors were defined. The data was analyzed using a repeated mixed model. An autoregressive covariance structure was used to consider the dependency among repeated measurements.
Outcome measures
| Measure |
Gas Movement Quantification With Double-lumen Tube
n=9 Participants
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
Gas Movement Quantification With Bronchial Blocker
n=10 Participants
For patients randomized to the gas movement quantification, a 2-liter bag was filled with 1000 mL of air with a 1000 mL calibrated syringe and a pneumotachometer through a 3-way valve prior to OLV. The pneumotachometer signal was amplified with Pneumotach Amplifier 1 and digitized at 200 Hz using MP100 analogic/numeric system. Volume were measured with ACQKnowledge by integration of flows measured with the pneumotachometer. One minute after initiation of OLV, the three-way valve was connected to the non-ventilated lumen of the DLT or to the internal chanel of the BB through an adaptor. Immediately prior to opening of the pleura, the volume measurement bag was closed and apnea was re-established in both groups for one minute as described above, after which measurements resumed for a total duration of 60 minutes of OLV. At the end of the observation period, the bag was emptied with the one-liter syringe through the pneumotachometer to measure its residual volume.
|
|---|---|---|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
0 minutes
|
0 cmH2O
Standard Error 0
|
0 cmH2O
Standard Error 0
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
1 minutes
|
-1.1 cmH2O
Standard Error 0.3
|
-0.7 cmH2O
Standard Error 1.2
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
2 minutes
|
-2.4 cmH2O
Standard Error 0.4
|
-2.6 cmH2O
Standard Error 1.7
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
3 minutes
|
-3.7 cmH2O
Standard Error 0.6
|
-4.9 cmH2O
Standard Error 2.6
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
4 minutes
|
-5.2 cmH2O
Standard Error 0.9
|
-8.9 cmH2O
Standard Error 4.5
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
5 minutes
|
-6.9 cmH2O
Standard Error 1.3
|
-11.9 cmH2O
Standard Error 5.6
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
6 minutes
|
-8.8 cmH2O
Standard Error 1.8
|
-14.2 cmH2O
Standard Error 8
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
7 minutes
|
-10.7 cmH2O
Standard Error 2.3
|
-18.1 cmH2O
Standard Error 9.4
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
8 minutes
|
-13.6 cmH2O
Standard Error 3.1
|
-19.7 cmH2O
Standard Error 9.2
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
9 minutes
|
-16.3 cmH2O
Standard Error 3.8
|
-24.6 cmH2O
Standard Error 12.0
|
|
Measurement of Intra-pulmonary Pressure in the Non-ventilated Lung With the Use of DLT and BB
10 minutes
|
-20.6 cmH2O
Standard Error 4.9
|
-28.3 cmH2O
Standard Error 13.6
|
Adverse Events
Intra-pulmonary Pressure Measurements With Double-lumen Tube
Intra-pulmonary Pressure Determination With Bronchial Blocker
Gas Movement Quantification With Double-lumen Tube
Gas Movement Quantification With Bronchial Blocker
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr Jean Bussières
Institut universitaire de cardiologie de de pneumologie de Québec
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place